Ara
Toplam kayıt 1, listelenen: 1-1
Fingolimod for the treatment of relapsing-remitting multiple sclerosis
(Turkish Neurological Society, 2017)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ...